WHAT TO KEEP IN MIND
Interest is not proof.
BPC 157 and TB 500 remain investigational, and much of the research is preclinical. Evidence about TB 500 must not be confused with the broader thymosin beta 4 research literature. These findings do not establish healing outcomes or a treatment combination.

